Dissection of the host-pathogen interaction in human tuberculosis using a bioengineered 3-dimensional model

  1. Liku B Tezera  Is a corresponding author
  2. Magdalena K Bielecka
  3. Andrew Chancellor
  4. Michaela T Reichmann
  5. Basim Al Shammari
  6. Patience Brace
  7. Alex Batty
  8. Annie Tocheva
  9. Sanjay Jogai
  10. Ben G Marshall
  11. Marc Tebruegge
  12. Suwan N Jayasinghe
  13. Salah Mansour
  14. Paul T Elkington  Is a corresponding author
  1. University of Southampton, United Kingdom
  2. King Abdullah International Medical Research Center, Saudi Arabia
  3. University College London, United Kingdom

Abstract

Cell biology differs between traditional cell culture and 3-dimensional (3-D) systems, and is modulated by the extracellular matrix. Experimentation in 3-D presents challenges, especially with virulent pathogens. Mycobacterium tuberculosis (Mtb) kills more humans than any other infection and is characterised by a spatially organised immune response and extracellular matrix remodelling. We developed a 3-D system incorporating virulent mycobacteria, primary human blood mononuclear cells and collagen-alginate matrix to dissect the host-pathogen interaction. Infection in 3-D led to greater cellular survival and permitted longitudinal analysis over 21 days. Key features of human tuberculosis develop, and extracellular matrix integrity favours the host over the pathogen. We optimised multiparameter readouts to study emerging therapeutic interventions: cytokine supplementation, host-directed therapy and immunoaugmentation. Each intervention modulates the host-pathogen interaction, but has both beneficial and harmful effects. This methodology has wide applicability to investigate infectious, inflammatory and neoplastic diseases and develop novel drug regimes and vaccination approaches.

Article and author information

Author details

  1. Liku B Tezera

    NIHR Respiratory Biomedical Research Unit, University of Southampton, Southampton, United Kingdom
    For correspondence
    l.tezera@soton.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
  2. Magdalena K Bielecka

    NIHR Respiratory Biomedical Research Unit, University of Southampton, Southampton, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  3. Andrew Chancellor

    NIHR Respiratory Biomedical Research Unit, University of Southampton, Southampton, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  4. Michaela T Reichmann

    NIHR Respiratory Biomedical Research Unit, University of Southampton, Southampton, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  5. Basim Al Shammari

    King Abdullah International Medical Research Center, Riyadh, Saudi Arabia
    Competing interests
    The authors declare that no competing interests exist.
  6. Patience Brace

    NIHR Respiratory Biomedical Research Unit, University of Southampton, Southampton, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  7. Alex Batty

    NIHR Respiratory Biomedical Research Unit, University of Southampton, Southampton, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  8. Annie Tocheva

    NIHR Respiratory Biomedical Research Unit, University of Southampton, Southampton, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  9. Sanjay Jogai

    NIHR Respiratory Biomedical Research Unit, University of Southampton, Southampton, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  10. Ben G Marshall

    NIHR Respiratory Biomedical Research Unit, University of Southampton, Southampton, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  11. Marc Tebruegge

    NIHR Respiratory Biomedical Research Unit, University of Southampton, Southampton, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  12. Suwan N Jayasinghe

    BioPhysics Group, UCL Institute of Biomedical Engineering, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  13. Salah Mansour

    NIHR Respiratory Biomedical Research Unit, University of Southampton, Southampton, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  14. Paul T Elkington

    NIHR Respiratory Biomedical Research Unit, University of Southampton, Southampton, United Kingdom
    For correspondence
    p.elkington@soton.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0390-0613

Funding

Medical Research Council (MR/N006631/1)

  • Paul T Elkington

National Institute of Allergy and Infectious Diseases (R33AI102239)

  • Suwan N Jayasinghe
  • Paul T Elkington

National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC/L001039/1)

  • Liku B Tezera
  • Paul T Elkington

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: For analysis of blood from healthy donors and healthy TB exposed individuals, this work was approved by the National Research Ethics Service committee South Central - Southampton A, study title 'An investigation into the immune response to tuberculosis infection and development of novel diagnostic markers', reference 13/SC/0043. All donors gave written informed consent. For histological analysis, samples used in this study were sourced from the Southampton Research Biorepository, University Hospital Southampton NHS Foundation Trust and University of Southampton, Mailpoint 218, Tremona Road, Southampton, SO16 6YD. Lung biopsy tissue was taken as part of routine clinical care and tissue blocks excess to diagnostic testing were analyzed in this study. The project was approved by the Institutional Review Board (Reference 12/NW/0794 SRB04_14). The ethics committee approved the analysis of this tissue without individual informed consent since it was surplus archived tissue taken as part of routine care.

Copyright

© 2017, Tezera et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,999
    views
  • 903
    downloads
  • 65
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

Share this article

https://doi.org/10.7554/eLife.21283

Further reading

    1. Immunology and Inflammation
    Alannah Lejeune, Chunyi Zhou ... Ken Cadwell
    Research Article

    Gastrointestinal (GI) colonization by methicillin-resistant Staphylococcus aureus (MRSA) is associated with a high risk of transmission and invasive disease in vulnerable populations. The immune and microbial factors that permit GI colonization remain unknown. Male sex is correlated with enhanced Staphylococcus aureus nasal carriage, skin and soft tissue infections, and bacterial sepsis. Here, we established a mouse model of sexual dimorphism during GI colonization by MRSA. Our results show that in contrast to male mice that were susceptible to persistent colonization, female mice rapidly cleared MRSA from the GI tract following oral inoculation in a manner dependent on the gut microbiota. This colonization resistance displayed by female mice was mediated by an increase in IL-17A+ CD4+ T cells (Th17) and dependent on neutrophils. Ovariectomy of female mice increased MRSA burden, but gonadal female mice that have the Y chromosome retained enhanced Th17 responses and colonization resistance. Our study reveals a novel intersection between sex and gut microbiota underlying colonization resistance against a major widespread pathogen.

    1. Immunology and Inflammation
    2. Structural Biology and Molecular Biophysics
    Colleen A Maillie, Kiana Golden ... Marco Mravic
    Research Article

    A potent class of HIV-1 broadly neutralizing antibodies (bnAbs) targets the envelope glycoprotein’s membrane proximal exposed region (MPER) through a proposed mechanism where hypervariable loops embed into lipid bilayers and engage headgroup moieties alongside the epitope. We address the feasibility and determinant molecular features of this mechanism using multi-scale modeling. All-atom simulations of 4E10, PGZL1, 10E8, and LN01 docked onto HIV-like membranes consistently form phospholipid complexes at key complementarity-determining region loop sites, solidifying that stable and specific lipid interactions anchor bnAbs to membrane surfaces. Ancillary protein-lipid contacts reveal surprising contributions from antibody framework regions. Coarse-grained simulations effectively capture antibodies embedding into membranes. Simulations estimating protein-membrane interaction strength for PGZL1 variants along an inferred maturation pathway show bilayer affinity is evolved and correlates with neutralization potency. The modeling demonstrated here uncovers insights into lipid participation in antibodies’ recognition of membrane proteins and highlights antibody features to prioritize in vaccine design.